Aimmune Therap (AIMT) Stock News
NASDAQ:AIMT - Nasdaq -
AIMT Latest News, Press Relases and Analysis
Aimmune Presents New Clinical Data From Pooled Safety Analysis in Patients Treated With PALFORZIA® for up to ~3.5 Years
Monteverde & Associates PC Files Class Action Lawsuit On Behalf Of Shareholders Of Aimmune Therapeutics, Inc. In The Northern District Of California
Company News for Sep1, 2020
Companies In The News Are: CTLT, TSLA, AIMT, AMZN.
Aimmune Therapeutics News: Why AIMT Stock Is Skyrocketing Today
Aimmune Therapeutics' news of its agreement with Nestle regarding its food allergy treatment has AIMT stock soaring way higher on Monday.
Best Stocks for 2020: Aimmune Therapeutics Gets Picked Up for a Steal
Nestle picked my Best Stocks pick up for a steal, but I believe the decade of biotechnology is just now getting started.
MERGER INVESTIGATION ALERT: Halper Sadeh LLP Reminds Investors About Its Ongoing Investigations; Shareholders are Encouraged to Contact the Firm – MNTA, VRTU, AIMT, MXIM
NEW YORK, NY / ACCESSWIRE / September 20, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Johnson & Johnson for $52.50 per share in cash. Visit our website to learn more about your rights and participate in an action:
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Aimmune Therapeutics, Inc. - AIMT
Nestle CEO Says 2021 Health Nutrition Sales to Exceed $4 Billion
Nestle SA forecast that its health nutrition business will reach about 4 billion Swiss francs ($4.4 billion) by the end of next year as the world’s largest food company expands in personalized supplements and allergy treatments.
ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm
Nestle initiates tender offer for Aimmune Therapeutics (OTCMKTS:NSRGY)
Nestle (OTCPK:NSRGY) subsidiary Société des Produits Nestlé S.A. (SPN) is commencing today a cash tender offer to purchase all of the outstanding common shares of Aimmune Therapeutics (NASDAQ:AIMT) for $34.50/share.
Nestlé commences tender offer for Aimmune Therapeutics, Inc.
ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm – AIMT, AKCA, PTI
NEW YORK, NY / ACCESSWIRE / September 12, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate: Aimmune Therapeutics, Inc. (NASDAQ:AIMT) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Sociétés des Produits Nestlé, S.A. for $34.50 per share. To learn more about your legal rights and options, visit:
SHAREHOLDER ALERT: WeissLaw LLP Reminds AKCA and AIMT Shareholders About Its Ongoing Investigations
Mentions: AKCA
Why Aimmune Therapeutics Stock Jumped by 159% in August
Nestle is buying the small-cap biotech, and it's paying a high premium.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm – MNTA, BMCH, RST, AIMT
NEW YORK, NY / ACCESSWIRE / September 5, 2020 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating: Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Johnson & Johnson for $52.50 per share in cash. To learn more about your legal rights and options, visit:
2 Mid-Cap Healthcare Stocks to Buy Now
These drugmakers are in the sweet spot to provide market-beating returns.
Stock Market Rally Pulls Back From Record Highs; Apple, Tesla, Zoom Video, Nvidia, Walmart In Focus
The stock market rally finally sold off, tumbling Thursday but finding support Friday. Apple, Tesla, Zoom Video, Nvidia and Walmart were newsmakers.
Rigrodsky & Long, P.A. Announces Investigation of Aimmune Therapeutics, Inc. Buyout
WILMINGTON, DE / ACCESSWIRE / September 1, 2020 / Rigrodsky & Long, P.A. announces that it is investigating Aimmune Therapeutics, Inc. ("Aimmune") (NASDAQ GS:AIMT) regarding possible breaches of fiduciary duties and other violations of law related to Aimmune's agreement to be acquired by Sociétés des Produits Nestlé, S.A. Under the terms of the agreement, Aimmune's shareholders will receive $34.50 per
Aimmune Set to be Acquired by Nestle for $2.6B, Stock Up
Aimmune (AIMT) reaches an agreement with Nestle, S.A wherein the latter will acquire the company in an all-cash transaction worth $2.6 billion. Shares surge.
Benzinga's Top Upgrades, Downgrades For September 1, 2020
Upgrades For Qualcomm Inc (NASDAQ: QCOM), Wells Fargo upgraded the previous rating of Underweight to the current rating Equal-Weight. For the third quarter, Qualcomm had an EPS...
10 Biggest Price Target Changes For Tuesday
Goldman Sachs raised the price target for Zoom Video Communications Inc (NASDAQ: ZM) from $187 to $402. Zoom Video shares rose 30% to $422.51 in pre-market trading. Wells Fargo...